Biotech grants in Spain
Explore Biotech grants for companies in Spain. This list brings together funding for drug discovery, diagnostics, cell and gene therapy, biomanufacturing and life-science research from Spanish innovation agencies, research funders and foundations, EU and international programs open to applicants in Spain, and competitions any company can enter, with the deadline, award size and eligibility on every listing. Grants aimed at Biotech in Spain come first.
Showing 169-192 of 635 grants
Optimising Advanced Therapy Medicinal Product (ATMP) Manufacturing
πͺπΊEuropean Commission Β· European Union
Funds industry-academia consortia that refine and scale up the manufacturing process for one class of cell or gene therapy, from quality control through to deployment.
Post-Infection Long-Term Conditions Research
πͺπΊEuropean Commission Β· European Union
Funds research into the prevention, diagnosis and treatment of long-term health conditions that persist after a viral, bacterial, parasitic or fungal infection has cleared.
PRECISEU Open Call β Joint Interregional Projects on Personalised Medicine
π©πͺEISMEA Β· European Union
Administers research teams and institutions for PRECISEU Joint Interregional Projects on Personalised Medicine in medical technology, biotechnology, and artificial intelligence.
Raising citizen awareness on alternative proteins derived from biotechnology
πͺπΊEuropean Commission Β· European Union
Pays one consortium to run a public-education and communication campaign on biotech-derived alternative proteins such as precision-fermentation foods.
Reconstructing areas affected by conflicts: the role of the bio-based solutions
πͺπΊEuropean Commission Β· European Union
Funds bio-based and nature-based reconstruction solutions for areas damaged by conflicts such as the wars in Ukraine and Gaza.
Research infrastructure services to enable R&I addressing main challenges and EU priorities
πͺπΊEuropean Commission Β· European Union
Funds transnational access to research infrastructure services in one of three areas β industrial biotechnology, radionuclide facilities, or climate prediction.
Retrofitting of (bio)refineries industrial plants towards higher-value bio-based products
πͺπΊCBE JU Β· European Union
Funds retrofitting an existing industrial or biorefinery plant to produce higher-value bio-based chemicals or materials than its old process line.
Scaling-up nutritional proteins from alternative sources
πͺπΊCBE JU Β· European Union
Funds scale-up of protein extraction or production processes from alternative sources like plants, fungi, microorganisms or fermentation, aimed at food use.
SPRIND Continuous Hormone Monitoring Challenge β Stage 1
π©πͺSPRIND Β· Germany
Funds teams in Germany through a continuous hormone-monitoring challenge for advanced sensor development.
SSbD bio-based polymers/copolymers unlocking new market applications
πͺπΊCBE JU Β· European Union
Funds scale-up of safe-and-sustainable bio-based polymers or co-polymers that match or beat fossil-based alternatives on performance.
SSbD bio-based solutions to replace hazardous conventional chemicals for textiles production
πͺπΊCBE JU Β· European Union
Funds demonstration of safe-and-sustainable bio-based chemicals or processes that replace hazardous coatings, dyes and solvents used in making textiles.
Strengthening and connecting bioeconomy networks
πͺπΊEuropean Commission Β· European Union
Pays one consortium to run an EU-wide bioeconomy networking platform connecting researchers, investors, policymakers and businesses.
Strengthening taxonomic approaches for biodiversity
πͺπΊEuropean Commission Β· European Union
Funds projects that build shared taxonomy databases or a European biodiversity genomics network to speed up species identification.
Strengthening the European Research Area by enhancing the bioeconomy research and innovation ecosystem in BIOEAST countries
πͺπΊEuropean Commission Β· European Union
Pays one consortium to align bioeconomy research funding and priorities across Central-Eastern Europe, Ukraine, Moldova and the Western Balkans.
Substances of concern and emerging pollutants from bio-based industries and products: mapping and replacement
πͺπΊEuropean Commission Β· European Union
Funds R&D into bio-based alternatives that replace hazardous chemicals like PFAS in industrial products and processes.
Sustainable macroalgae systems for innovative, added-value applications: cultivation and optimised production systems
πͺπΊCBE JU Β· European Union
Funds companies scaling up sustainable macroalgae cultivation and turning the harvest into new bio-based food, feed or industrial products.
Tackling Diarrhoeal Diseases in the Context of Climate and Health
πͺπΊEDCTP3 Β· European Union
Funds late-stage clinical trials of treatments and diagnostics for six climate-linked diarrhoeal disease pathogens in sub-Saharan Africa.
Tackling High-Burden, Under-Researched Medical Conditions
πͺπΊEuropean Commission Β· European Union
Funds clinical and pre-clinical research that pins down the causes of, and builds better diagnostics and treatments for, medical conditions that are common but poorly understood, such as ME/CFS, autism, gynaecological diseases and low back pain.
TRANSCAN-4 JTC-2026
π΅π±NCBR Β· Poland
Co-funds Polish translational cancer-metabolism research done with an international team.
Transformative Innovations in Global Health
πͺπΊEDCTP3 Β· European Union
Funds beyond-proof-of-concept innovations that make infectious-disease prevention, treatment or diagnostics cheaper, more accessible or better suited to sub-Saharan Africa.
Translating Disruptive New Approach Methodologies (NAMs) into Practice
πͺπΊEuropean Commission Β· European Union
Pays biomedical New Approach Methodology developers a fixed EUR 300,000 lump-sum grant to validate animal-free testing methods and prepare them for regulatory use.
Understanding how infections foster and induce non-communicable diseases
πͺπΊIHI JU Β· European Union
Funds one project mining research cohorts and biobanks to find causal links between infections and non-communicable diseases, aimed at new vaccines, diagnostics and early treatments.
Understanding the effects of environmental exposure on the risk of paediatric, adolescent and young adult cancers
πͺπΊEuropean Commission Β· European Union
Funds research into how environmental exposures interact with genetic and lifestyle factors to cause cancer in children, adolescents and young adults.
Unleashing the potential and advancing the impact of the digitalization/Artificial Intelligence of the climate-neutral bio-based value chains
πͺπΊEuropean Commission Β· European Union
Funds AI and digital-twin tools that speed up bio-based manufacturing β from biorefinery process control to predicting biosynthesis pathways.